|
⚲
|
| CytomX Therapeutics LLC | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001465584 |
| Sale | 2009-06-01 ($2.5 M Offered, $2.5 M Sold) |
| Fund | |
| Phone | 8059649700 |
| Address | 460 Ward Drive, Ste E1 Santa Barbara, 93111 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Nancy Stagliano | |
| Michael Pfau |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Industry Ventures Partnership Holdings III-B, L.P.
✚
|
0.0 | |
|
Industry Ventures Secondary X, L.P.
✚
|
0.0 | |
|
Industry Ventures Tech Buyout, LP
✚
|
0.0 | |
|
Pathmatics, Inc.
✚
|
0.0 | |
|
Path Shoreline, LP
✚
|
0.0 | |
|
Ineedmd,Inc.
✚
|
0.0 | |
|
Inference AP Fund V, a Series of Vauban Platform LP
✚
|
0.0 | |
|
Infield, Inc.
✚
|
0.0 | |
|
Infinite AI, Inc.
✚
|
0.0 | |
|
Industry Ventures Partnership Holdings III-A, L.P.
✚
|
0.0 |